[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Guided Therapeutics Inc (GTHP)

Guided Therapeutics Inc (GTHP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Guided Therapeutics Inc 5835 PEACHTREE CORNERS EAST SUITE B PEACHTREE CORNERS GA 30092 USA

www.guidedinc.com Employees: 3 P: 770-242-8723

Sector:

Medical

INDUSTRY GROUPING:

Medical Products

Description:

GUIDED THERAPEUTICS, Inc. is developing a rapid and painless test for the early detection of disease that leads to cervical cancer. The technology is designed to quickly eliminate false positive Pap and HPV results and discover cervical disease missed by existing tests. Unlike Pap and HPV tests, the device does not require a painful tissue sample and results are available immediately. GT also owns technology for measuring substances in interstitial fluid, a secondary circulatory system in the body that surrounds the cells.

Key Statistics

Overview:

Market Capitalization, $K 23,652
Enterprise Value, $K 25,872
Shares Outstanding, K 96,537
Float, K 32,021
% Float 33.17%
Short Interest, K 32
Short Float 0.03%
Days to Cover 7.94
Short Volume Ratio 0.10
% of Insider Shareholders 66.83%
% of Institutional Shareholders 9.69%

Financials:

Annual Sales, $ 770 K
Annual Net Income, $ -3,200 K
Last Quarter Sales, $ 590 K
Last Quarter Net Income, $ -1,220 K
EBIT, $ -2,370 K
EBITDA, $ -2,020 K

Growth:

1-Year Return 5.46%
3-Year Return 15.24%
5-Year Return -62.31%
5-Year Revenue Growth 670.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.01 on 05/15/26
Next Earnings Date 08/13/26
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 0.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-800 on 03/29/19

GTHP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -274.24%
Profit Margin % -415.58%
Debt/Equity -0.11
Price/Sales 30.21
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.07
Interest Coverage -4.16
60-Month Beta 0.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.